School personnel information

写真b

TSUTSUMI Yasuo


Keyword

Toxicology, Proteomics, Biomaker

URL

http://www.phs.osaka-u.ac.jp/homepage/b009/index.htm

Organization 【 display / non-display

  • 1998.04.01 - 2004.03.31, Applied Biopharamaceutical Sciences, Graduate School of Pharmaceutical Sciences, Research Assistant, full time

  • 2008.04.01 - 2012.03.31, Applied Biopharamaceutical Sciences, Graduate School of Pharmaceutical Sciences, Professor, full time

  • 2012.04.01 - , Advanced Pharmaco-science, Graduate School of Pharmaceutical Sciences, Professor, full time

Education 【 display / non-display

Osaka University Faculty of Pharmaceutical Science  Graduated 1991.03
Osaka University Graduate School, Division of Pharmaceutical Sciences  Completed 1993.03
Osaka University Graduate School, Division of Pharmaceutical Sciences  Unfinished 1994.08

Employment Record 【 display / non-display

Department of Toxicology, Graduate School of Pharmaceutical Sciences, Osaka University 2008.04 -

Research topics 【 display / non-display

  • 1)Toxicological assessment of xenobiotics such as drugs, food additives, cosmetics, 2)Toxicokinetic and toxicodynamic research on nanomaterials for clarification of their toxicity-mechanism, 3)Safety evaluation of nanomaterials (Nanotox study) by proteome analysis for their risk management
    Biomedical engineering/ Biological material science, Medical pharmacy, Environmental pharmacy, Drug development chemistry

Academic Society Membership 【 display / non-display

  • Society of Environmental Toxicology and Chemistry

  • European Societies of Toxicology

  • Society of Toxicology

 

Academic Papers 【 display / non-display

  • Hepatotoxicity of sub-nanosized platinum particles in mice, Yoshiaki YAMAGISHI, Akihiro WATARI, Yuya HAYATA, Xiangru LI, Masuo KONDOH, Yasuo TSUTSUMI, Kiyohito YAGI, Pharmazie, 2013.03, Papers

  • Rho GDP-dissociation inhibitor alpha is associated with cancer metastasis in colon and prostate cancer., Yamashita T, Okamura T, Nagano K, Imai S, Abe Y, Nabeshi H, Yoshikawa T, Yoshioka Y, Kamada H, Tsutsumi Y, Tsunoda S., Pharmazie, 2012.03, Papers

  • Amorphous silica nanoparticles size-dependently aggravate atopic dermatitis-like skin lesions following an intradermal injection, Hirai T, Yoshikawa T, Nabeshi H, Yoshida T, Tochigi S, Ichihashi K, Uji M, Akase T, Nagano K, Abe Y, Kamada H, Itoh N, Tsunoda S, Yoshioka Y, Tsutsumi Y., Part. Fibre. Toxicol, 9(1): 3, 2012.02, Papers

  • Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure, Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Arimori A, Isobe M, Tochigi S, Kondoh S, Hirai T, Akase T, Yamashita T, Yamashita K, Yoshida T, Nagano K, Abe Y, Yoshioka Y, Kamada H, Imazawa T, Kondoh M, Yagi K, Mayumi T, Itoh N, Tsunoda S, Tsutsumi Y., Nanotechnol, 23: 1-8, 2012.02, Papers

  • Novel TNF-alpha receptor-1 antagonist treatment attenuates arterial inflammation and intimal hyperplasia in mice., Kitagaki M, Isoda K, Kamada H, Kobayashi T, Tsunoda S, Tsutsumi Y, Niida T, Kujiraoka T, Ishigami N, Ishihara M, Matsubara O, Ohsuzu F, Kikuchi M., J. Atheroscler. Thromb., 2011.12, Papers

display all >>